[SCHEDULE 13G/A] Modular Medical, Inc. SEC Filing

Rhea-AI Filing Summary

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh reported collective beneficial ownership of Modular Medical, Inc. common stock equal to 2,068,958 shares, representing 3.81% of the outstanding class based on 54,247,388 shares. The filing shows no sole voting or dispositive power; all voting and dispositive power is shared. An exhibit clarifies the holders directly own 1,548,125 shares and hold warrants to purchase 520,833 shares. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing control. Signatures for the filers are included.

Insights

Securities Analyst

TL;DR: A small, non-controlling 3.81% stake reported, split between shares and warrants; no sole voting control.

The filing documents that the reporting persons collectively hold 2,068,958 shares of Modular Medical, Inc., representing 3.81% of the class based on the issuer's June 20, 2025 10-Q share count. Voting and disposition rights are shared, with zero sole power reported. The exhibit clarifies a breakdown of 1,548,125 directly owned shares plus warrants for 520,833 shares. The statement affirms ordinary-course acquisition and disclaims any intent to influence control. Given the sub-5% stake and lack of sole control, this is a routine disclosure without indicated activism or control intent.

Corporate Governance Expert

TL;DR: Ownership structure signals engaged investor participation but not a control position; governance impact appears limited.

The report shows shared voting and dispositive power across the reporting group rather than concentrated, sole authority. The presence of warrants increases potential economic exposure but the combined position equals 3.81% of outstanding shares per the referenced 10-Q, below thresholds that typically trigger control presumptions. The certification language and joint filing statement are standard. There is no indication of a group formation seeking to change board composition or corporate control based on the filing.

08/14/2025 - 05:24 PM

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

MODULAR MEDICAL, INC.

(Name of Issuer)

Common Stock Par Value $.001 per Share

(Title of Class of Securities)

60785L207

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 60785L207

1

Names of Reporting Persons

Alyeska Investment Group, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,041,666.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,041,666.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,041,666.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.81 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 60785L207

1

Names of Reporting Persons

Alyeska Fund GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,041,666.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,041,666.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,041,666.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.81 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 60785L207

1

Names of Reporting Persons

Anand Parekh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,068,958.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,068,958.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,068,958.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.81 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MODULAR MEDICAL, INC.
(b)	Address of issuer's principal executive offices: 10740 Thornmint Road, San Diego, CA 92127
Item 2.
(a)	Name of person filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b)	Address or principal business office or, if none, residence: (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601
(c)	Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)	Title of class of securities: Common Stock Par Value $.001 per Share
(e)	CUSIP No.: 60785L207
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,068,958
(b)	Percent of class: 3.81%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 2,068,958
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2,068,958
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alyeska Investment Group, L.P.

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2025

Alyeska Fund GP, LLC

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2025

Anand Parekh

Signature:	Anand Parekh
Name/Title:	Anand Parekh | Self
Date:	08/14/2025

Exhibit Information

Item 4. Ownership: The reporting persons are the beneficial owners of 1,548,125 shares of Common Stock of the Issuer and hold warrants to purchase 520,833 shares of the Issuer's Common Stock (the "Warrants"). The percentage calculation assumes that there are currently 54,247,388 outstanding shares of Common Stock of the Issuer, based on the Issuer's 10-Q filed with the Securities and Exchange Commission on June 20, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

FAQ

How many Modular Medical (MODD) shares do the reporting persons beneficially own?

The reporting persons collectively beneficially own 2,068,958 shares of Modular Medical common stock.

What percentage of Modular Medical does the 13G/A filing report?

The filing reports ownership equal to 3.81% of the outstanding common stock, based on 54,247,388 shares.

Do the reporting persons have sole voting or dispositive power over the shares?

No. The filing indicates 0 shares with sole voting or dispositive power; all reported power is shared.

Does the filing indicate any intent to change or influence control of Modular Medical?

No. The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.

Do the reporting persons hold any warrants related to Modular Medical?

Yes. The exhibit states they hold warrants to purchase 520,833 shares in addition to 1,548,125 directly owned shares.